Comparative outcomes for tirzepatide versus glucagon-like peptide-1 receptor agonists in patients with inflammatory bowel disease: a national propensity matched study.
- DOI
- 10.5217/ir.2026.00152
- Published
- 2026 Sep 10
- Container
- Intestinal research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.5217/ir.2026.00152,
title = {Comparative outcomes for tirzepatide versus glucagon-like peptide-1 receptor agonists in patients with inflammatory bowel disease: a national propensity matched study.},
author = {Patel KS and Fakhoury B and Parmar K and Jahagirdar V and Sanyal AJ and Arab JP and Tariq R},
year = {2026},
journal = {Intestinal research},
doi = {10.5217/ir.2026.00152},
url = {https://doi.org/10.5217/ir.2026.00152}
}RIS
TY - JOUR TI - Comparative outcomes for tirzepatide versus glucagon-like peptide-1 receptor agonists in patients with inflammatory bowel disease: a national propensity matched study. AU - Patel KS AU - Fakhoury B AU - Parmar K AU - Jahagirdar V AU - Sanyal AJ AU - Arab JP AU - Tariq R PY - 2026 JO - Intestinal research DO - 10.5217/ir.2026.00152 UR - https://doi.org/10.5217/ir.2026.00152 ER -
APA
KS, P., B, F., K, P., V, J., AJ, S., JP, A., & R, T. (2026). Comparative outcomes for tirzepatide versus glucagon-like peptide-1 receptor agonists in patients with inflammatory bowel disease: a national propensity matched study.. Intestinal research. https://doi.org/10.5217/ir.2026.00152
Source records
- pubmed · retrieved 2026-09-25T08:31:39.952Z